查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1862862

多體學市場：按技術、體學、產品類型、應用和最終用戶分類 - 全球預測 2025-2032

Multiomics Market by Technology, Omics, Product Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，多體學市場將成長至 3,347.5 億美元，複合年成長率為 16.76%。

關鍵市場統計數據
基準年 2024 968.6億美元
預計年份：2025年 1129.9億美元
預測年份 2032 3347.5億美元
複合年成長率 (%) 16.76%

策略性地將多組體學定位為一個綜合領域，該領域結合了技術進步、數據管治和轉化重點，以指導投資。

多組體學正在重塑機構提出和解決生物學挑戰的方式。本文將該領域定位在技術、資料科學和轉換應用目標的交會點。過去十年，研究人員已從孤立的檢測方法轉向整合來自基因組學、轉錄組學、蛋白質組學、代謝體學、脂質組學和表觀基因的多層數據的策略。這揭示了單體學方法常常忽略的機制性見解。因此，實驗設計現在同樣重視樣本完整性、統一的元資料和分析的可重複性，從而支持跨體學的可比較性。

隨著多組體學應用從發現生物學擴展到臨床診斷、藥物研發和個人化醫療，相關人員不得不協調不同的監管要求、資料管治框架和檢驗標準。這種發展趨勢凸顯了標準化通訊協定和可互通資料格式的重要性，同時也推動了對能夠將異質資料集轉化為具有臨床意義的特徵的分析平台的需求。此外，定序化學、質譜靈敏度和計算工具的進步正在降低技術壁壘，並促進濕實驗室研究人員、生物資訊學家和臨床醫生之間的跨學科合作。

綜上所述，這些趨勢清楚地表明，多組體學既是科學發展的驅動力，也是策略優勢。那些能夠最佳化組織流程、投資可重複工作流程並培養數據驅動文化的機構，將更有利於充分利用整合分子譜分析的轉換價值。本執行摘要的其餘部分說明深入探討影響多組學應用和競爭差異化的變革性轉變、政策影響、市場區隔洞察以及區域性因素。

融合技術的出現、監管法規的演變以及對檢驗的轉化工作流程的需求，正在推動多組體學應用發生重大變革。

多體學領域正經歷著變革性的轉變，這主要得益於技術的整合進步、臨床需求的演變以及新興資料科學能力的湧現。定序通量和準確性的提高、質譜平台的增強以及自動化樣本製備流程的改進，正在降低技術門檻，並拓展可行的研究設計範圍。同時，機器學習和網路生物學領域的演算法創新釋放新的解讀層面，使研究人員能夠從複雜的多維資料集中提取基於機制的假設。

同時，監管和倫理方面的考量正在重塑組織機構的資料管理方式。對資料來源可追溯性、審核和跨機構資料共用的日益重視，正在加速對安全平台和聯合分析模型的投資，這些平台和模型能夠在保護病患隱私的同時，支持大規模的綜合研究。臨床上對可操作生物標記的需求，以及對分析有效性和臨床效用日益成長的期望，正迫使開發人員優先考慮可重複且透明的性能指標。

在營運方面，目前正明顯轉向端到端解決方案，這些方案提供檢驗的工作流程，整合耗材、設備和服務。這一趨勢有助於加快轉換速度，並減輕最終用戶的整合負擔。這些變化正在創造一個環境，​​在這個環境中，策略夥伴關係、平台間的互通性以及可證實的臨床影響將決定長期的成功。

分析關稅帶來的供應鏈壓力如何迫使體學學價值鏈採取在地化、供應商多元化和彈性籌資策略。

2025年美國關稅政策對多組體學生態系統內的供應鏈韌性、籌資策略和成本結構提出了新的考量。實驗室設備、試劑和進口組件的關稅可能會增加到岸成本，促使製造商和採購商評估其他採購方案、實現關鍵生產過程的本地化或重新談判供應商合約。為此，許多機構正在重新評估其平台投資的整體擁有成本，並優先考慮供應鏈透明且製造地分佈廣泛的供應商。

這些政策轉變也凸顯了區域夥伴關係和分散式製造模式的戰略價值。能夠擴大本地組裝、耗材生產和試劑填充能力的企業將在關稅壓力下獲得競爭優勢，而擁有靈活且區域分佈的實驗室的服務供應商可以通過將樣品處理重新分配到貿易條件有利、進口關稅較低的設施來降低風險。

在採購方面，實驗室和商業檢測實驗室擴大採用多年期合約、避險策略和庫存管理技術來應對短期價格波動。同時，對上游採購計畫的透明度需求日益成長，供應商審核和涵蓋關稅相關風險的合約條款也變得越來越重要。因此，政策環境正推動產業建構更具韌性、更透明、地理分佈更廣的供應鏈，以在管理營運風險的同時，維持科學研究工作的連續性。

全面的細分分析揭示了技術選擇、體學方法、產品類型、應用領域和最終用戶需求如何決定採用路徑和價值創造。

關鍵的市場區隔分析揭示了技術選擇、科學研究重點和終端用戶需求之間的交集，從而塑造了技術應用路徑和價值提案。按技術分類，市場涵蓋質譜、微陣列、qPCR 和定序，其中定序又細分為次世代定序(NGS) 和桑格定序。這項技術組合決定了研究人員可應用的下游分析的通量、靈敏度和性質。體學領域涵蓋表觀表觀基因、基因組學、脂質組學、代謝體學、蛋白質組學和轉錄組學。每個體學層面都提供獨特的生物學背景，同時也帶來了與樣品製備、動態範圍和數據整合相關的分析挑戰。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 推出精準腫瘤學研究的AI驅動多體學資料整合平台
  • 空間轉錄組學和蛋白​​質組學融合技術的出現，為繪製腫瘤微環境圖譜提供了可能。
  • 整合代謝體學和表觀基因以識別神經退化性疾病中的新型生物標記
  • 對雲端基礎的多組體學分析工作流程的需求日益成長，以簡化大規模資料處理。
  • 開發用於快速照護現場的攜帶式多體學檢體製備試劑套件
  • 擴大液態生物檢體體學學檢測規模，用於早期癌症檢測和微量殘存疾病監測
  • 製藥公司與多體學技術提供者在藥物標靶發現方面的合作日益增多。
  • 利用體學和體學的整合進行個人化營養管理和代謝疾病管理

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依科技分類的多組體學市場

  • 質譜分析
  • 微陣列
  • qPCR
  • 定序
    • 次世代定序
    • 桑格定序

第9章：多體學體學市場

  • 表觀基因
  • 基因組學
  • 脂質體學
  • 代謝體學
  • 蛋白質體學
  • 轉錄組學

第10章 多組體學市場（依產品類型分類）

  • 消耗品
  • 裝置
  • 軟體和服務
    • 服務
      • 數據分析
      • 樣品製備
    • 軟體

第11章 多組體學市場按應用領域分類

  • 農業和食品檢驗
  • 生物標記發現
  • 臨床診斷
  • 藥物發現與開發
  • 個人化醫療

第12章 依最終用戶分類的多組體學市場

  • 學術研究機構
  • CRO（受託研究機構）
  • 醫院和診斷實驗室
  • 製藥和生物技術公司

第13章：各地區的多組體學市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 多組體學市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國多組體學市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Danaher Corporation
    • Roche Holding AG
    • Agilent Technologies, Inc.
    • QIAGEN NV
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Bruker Corporation
    • Waters Corporation
Product Code: MRR-CF699CF41428

The Multiomics Market is projected to grow by USD 334.75 billion at a CAGR of 16.76% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 96.86 billion
Estimated Year [2025] USD 112.99 billion
Forecast Year [2032] USD 334.75 billion
CAGR (%) 16.76%

A strategic introduction framing multiomics as an integrative discipline that fuses technological advances, data governance, and translational priorities to guide investment

Multiomics is reshaping how organizations ask and answer biological questions, and this introduction situates the field at the intersection of technology, data science, and translational ambition. Over the past decade, practitioners have moved beyond siloed assays to integrated strategies that layer genomics, transcriptomics, proteomics, metabolomics, lipidomics, and epigenomics data to reveal mechanistic insights that single-omic approaches often miss. Consequently, experimental design now places equal emphasis on sample integrity, harmonized metadata, and analytical reproducibility to support cross-omic comparability.

As multiomics applications expand from discovery biology into clinical diagnostics, drug development, and personalized medicine, stakeholders must reconcile differing regulatory expectations, data governance frameworks, and validation requirements. This evolution elevates the importance of standardized protocols and interoperable data formats, while simultaneously driving demand for analytics platforms that translate heterogenous datasets into clinically meaningful signatures. Moreover, advances in sequencing chemistry, mass spectrometry sensitivity, and computational tools have reduced technical barriers, encouraging cross-disciplinary collaboration among wet-lab scientists, bioinformaticians, and clinicians.

Taken together, these dynamics position multiomics as both a scientific enabler and a strategic lever. Institutions that align organizational processes, invest in reproducible workflows, and foster data-driven cultures are best placed to capture the translational value of integrated molecular profiling. The remainder of this executive summary unpacks the transformative shifts, policy impacts, segmentation insights, and regional considerations that will shape adoption and competitive differentiation.

Key transformative shifts reshaping multiomics adoption driven by convergent technologies, regulatory evolution, and demand for validated translational workflows

The landscape of multiomics is undergoing transformative shifts driven by converging technological advances, evolving clinical priorities, and emergent data science capabilities. Improvements in sequencing throughput and accuracy, enhanced mass spectrometry platforms, and automated sample preparation workflows are lowering technical friction and expanding the range of feasible study designs. Simultaneously, algorithmic innovations in machine learning and network biology are unlocking new interpretive layers, enabling researchers to extract mechanistic hypotheses from complex, multi-dimensional datasets.

At the same time, regulatory and ethical considerations are reshaping how organizations approach data stewardship. Greater emphasis on provenance, auditability, and cross-institutional data sharing is accelerating investments in secure platforms and federated analysis models that preserve patient privacy while enabling large-scale integrative studies. Clinical demand for actionable biomarkers, coupled with heightened expectations for analytical validation and clinical utility, is pushing developers to prioritize reproducibility and transparent performance metrics.

Operationally, there is a clear move toward end-to-end solutions that combine consumables, instruments, and services into validated workflows. This trend supports faster translational timelines and reduces the integration burden for end users. Taken together, these shifts create an environment where strategic partnerships, platform interoperability, and demonstrable clinical impact determine long-term success.

Analyzing how tariff-driven supply chain pressures compel localization, supplier diversification, and resilient procurement strategies across the multiomics value chain

The 2025 tariff environment in the United States has introduced tangible considerations for supply chain resilience, procurement strategy, and cost structure within the multiomics ecosystem. Tariffs on laboratory instruments, reagents, or imported components can increase landed costs, prompting manufacturers and buyers to evaluate sourcing alternatives, localize critical production steps, or renegotiate supplier agreements. In response, many organizations are reassessing total cost of ownership for platform investments and prioritizing vendors that demonstrate transparent supply chains and diversified manufacturing footprints.

These policy shifts also amplify the strategic value of regional partnerships and distributed manufacturing models. Firms that can scale localized assembly, consumable production, or reagent fill-and-finish capacities gain a competitive advantage under tariff pressures. Meanwhile, service providers with flexible, regionally distributed laboratories can mitigate exposure by reallocating sample processing to facilities with preferential trade terms or lower import duties.

From a procurement perspective, research institutions and commercial labs are increasingly adopting multi-year contracts, hedging strategies, and inventory management practices to absorb short-term price volatility. At the same time, the need for clear visibility into upstream component sourcing has elevated supplier audits and contractual clauses that address tariff-related liabilities. Ultimately, the policy environment is pushing the sector toward more resilient, transparent, and geographically diversified supply chains that preserve scientific continuity while controlling operational risk.

Comprehensive segmentation insights revealing how technology choices, omic modalities, product types, applications, and end-user needs determine adoption pathways and value creation

Key segmentation insights reveal where technological choices, scientific priorities, and end-user needs intersect to shape adoption pathways and value propositions. Based on Technology, the market encompasses Mass Spectrometry, Microarrays, qPCR, and Sequencing, with Sequencing further segmented into Next Generation Sequencing and Sanger Sequencing; this technological palette determines throughput, sensitivity, and the nature of downstream analytics that researchers can apply. Based on Omics, the field spans Epigenomics, Genomics, Lipidomics, Metabolomics, Proteomics, and Transcriptomics; each omic layer contributes distinct biological context and poses unique analytical challenges related to sample prep, dynamic range, and data integration.

Based on Product Type, offerings include Consumables, Instruments, and Software and Services, with Software and Services further differentiated into Services and Software, and Services subdivided into Data Analysis and Sample Preparation; such product taxonomy underscores the growing importance of bundled solutions that combine hardware with analytical and preparatory services. Based on Application, primary use cases encompass Agriculture and Food Testing, Biomarker Discovery, Clinical Diagnostics, Drug Discovery and Development, and Personalized Medicine; these applications drive differing requirements for regulatory compliance, throughput, and interpretive frameworks. Based on End User, the ecosystem serves Academic and Research Institutes, Contract Research Organizations, Hospitals and Diagnostic Laboratories, and Pharmaceutical and Biotechnology Companies; each end-user segment prioritizes distinct value drivers, from exploratory flexibility to validated, clinically compliant workflows.

Interpreting these segmentations together highlights where investments will matter most: platforms that enable high-quality sample processing, interoperable data pipelines that support multi-omic integration, and services that reduce technical barriers for non-specialist end users. In short, success hinges on aligning technological capabilities with application-specific needs and end-user operational realities.

Actionable regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence adoption, regulation, and partnership strategies in multiomics

Regional dynamics exert a powerful influence on technology deployment, regulatory alignment, and partnership strategies across the multiomics landscape. In the Americas, research intensity, venture funding, and a robust network of biotech clusters drive rapid adoption of advanced sequencing and mass spectrometry platforms, while a complex patchwork of reimbursement and regulatory frameworks requires targeted validation strategies. Meanwhile, academic-industry collaborations and contract research organizations in the region foster translational pipelines that accelerate proof-of-concept studies and early clinical adoption.

Across Europe, Middle East & Africa, regulatory harmonization efforts, strong public research infrastructures, and growing commercial investment support methodical integration of multiomics into healthcare and agricultural applications. Stakeholders in these markets often prioritize interoperability, data protection, and harmonized performance standards, creating demand for validated workflows and compliant analytics. In Asia-Pacific, rapid infrastructure build-out, manufacturing scale, and government-led science initiatives are expanding local production capacities and driving aggressive adoption of sequencing technologies and automated sample handling systems. The region's diverse regulatory environments and large patient populations also create opportunities for large-scale cohort studies and localized biomarker discovery.

Collectively, these regional characteristics underscore the need for geographically nuanced strategies. Organizations must tailor commercialization, regulatory, and partnership approaches to regional priorities, balancing global platform standardization with local operational flexibility.

Key company insights highlighting how platform integration, validation capabilities, and service differentiation determine competitive advantage across multiomics players

Competitive dynamics in multiomics center on the ability to deliver reliable, validated end-to-end solutions that combine high-performance instruments, reproducible consumables, and scalable analytics. Key companies distinguish themselves through investments in platform interoperability, demonstrated clinical or agricultural utility, and partnerships that extend their value proposition into downstream applications. Strategic M&A and partnership activity continues to align specialized capabilities-such as niche sample preparation chemistry or advanced informatics-with broader platform providers seeking comprehensive offerings.

Market differentiation also arises from service excellence; organizations that provide robust validation support, regulatory documentation, and training resources secure deeper customer relationships. Similarly, firms that offer modular software with open APIs facilitate integration into existing laboratory information management systems and analysis pipelines, lowering barriers for enterprise adoption. Investors and strategic partners increasingly prize companies that demonstrate end-user-focused commercialization strategies, geographic manufacturing resilience, and transparent data governance practices. Ultimately, market leaders combine technical credibility with commercial agility, enabling them to scale adoption across academic, clinical, and industrial customers.

Actionable recommendations for industry leaders to enhance platform interoperability, supply chain resilience, regulatory support, and service-led commercialization strategies

Industry leaders can accelerate value capture by aligning strategic actions with technological and regulatory realities while prioritizing resilience and customer-centricity. First, investing in interoperable platforms and open data standards reduces integration friction and increases the appeal of solutions across end users with heterogeneous infrastructure. Next, expanding localized manufacturing or establishing regional partnerships mitigates tariff and supply chain risks, while offering faster turnaround times for critical consumables and reagents.

Additionally, integrating comprehensive validation packages and regulatory support into product offerings lowers adoption barriers in clinical and diagnostic contexts. Leaders should also develop tiered service models that include sample preparation, data analysis, and clinical interpretation to address the needs of both high-throughput research centers and diagnostic laboratories. To cultivate long-term trust, companies must implement transparent data governance frameworks and robust provenance tracking to satisfy institutional and regulatory auditors. Finally, strengthening cross-disciplinary talent pipelines-combining wet-lab expertise, computational biology, and regulatory affairs-ensures organizations can translate multiomic data into actionable biological and clinical insights. These recommendations form a pragmatic blueprint for organizations seeking to scale responsibly and sustainably.

A rigorous mixed-methods research methodology combining expert primary interviews with systematic secondary evidence synthesis to ensure analytic validity and relevance

The research methodology blends primary and secondary evidence to ensure analytical rigor, reproducibility, and relevance. Primary research included structured interviews with domain experts, laboratory directors, and service providers to capture operational realities, validation practices, and procurement drivers. These qualitative inputs were triangulated with technical literature, peer-reviewed studies, and vendor documentation to verify claims about platform capabilities, assay limitations, and analytical workflows.

Secondary research encompassed a systematic review of scientific publications, regulatory guidance documents, and white papers that illuminate technological trends and application-specific requirements. Data collection prioritized sources that detail assay performance characteristics, sample handling best practices, and interoperability standards. Findings were synthesized using thematic analysis and cross-validation steps to surface consistent patterns and areas of divergence. Throughout the process, attention to provenance, methodological transparency, and source credibility underpinned analytical choices, ensuring that conclusions rest on verifiable evidence and reflect current industry practices.

A conclusive synthesis emphasizing the need for validated workflows, interoperable platforms, and resilient commercialization strategies to realize multiomics impact

In conclusion, multiomics represents a strategic inflection point in life sciences where integrated molecular profiling, advanced instrumentation, and sophisticated analytics converge to enable deeper biological insight and translational impact. The field's maturation depends on aligning technological innovation with robust data governance, standardized workflows, and commercially viable service models that lower barriers to adoption. Policy shifts and trade dynamics have highlighted the importance of supply chain resilience and regional agility, making localization and partnership strategies central to long-term operational continuity.

Looking ahead, organizations that prioritize platform interoperability, end-to-end validation, and customer-focused service offerings will be best positioned to translate multiomic data into clinical and commercial outcomes. Cross-sector collaboration among instrument vendors, software developers, service providers, and end users will accelerate the development of validated workflows and reproducible evidence, thereby expanding the range of practical applications. Ultimately, the pathway to impact lies in coupling scientific rigor with pragmatic commercialization and governance frameworks that foster trust, scalability, and measurable benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven multiomics data integration platforms for precision oncology research
  • 5.2. Emergence of spatial transcriptomics combined with proteomics to map tumor microenvironments
  • 5.3. Integration of metabolomics and epigenomics analyses to identify novel biomarkers in neurodegenerative diseases
  • 5.4. Rising demand for cloud-based multiomics analysis workflows to streamline large dataset processing
  • 5.5. Development of portable multiomics sample preparation kits for rapid point-of-care diagnostics
  • 5.6. Expansion of liquid biopsy multiomics assays for early cancer detection and minimal residual disease monitoring
  • 5.7. Increasing partnerships between pharma and multiomics technology providers for drug target discovery
  • 5.8. Utilization of lipidomics and glycomics integration in personalized nutrition and metabolic disorder management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Multiomics Market, by Technology

  • 8.1. Mass Spectrometry
  • 8.2. Microarrays
  • 8.3. qPCR
  • 8.4. Sequencing
    • 8.4.1. Next Generation Sequencing
    • 8.4.2. Sanger Sequencing

9. Multiomics Market, by Omics

  • 9.1. Epigenomics
  • 9.2. Genomics
  • 9.3. Lipidomics
  • 9.4. Metabolomics
  • 9.5. Proteomics
  • 9.6. Transcriptomics

10. Multiomics Market, by Product Type

  • 10.1. Consumables
  • 10.2. Instruments
  • 10.3. Software and Services
    • 10.3.1. Services
      • 10.3.1.1. Data Analysis
      • 10.3.1.2. Sample Preparation
    • 10.3.2. Software

11. Multiomics Market, by Application

  • 11.1. Agriculture and Food Testing
  • 11.2. Biomarker Discovery
  • 11.3. Clinical Diagnostics
  • 11.4. Drug Discovery and Development
  • 11.5. Personalized Medicine

12. Multiomics Market, by End User

  • 12.1. Academic and Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals and Diagnostic Laboratories
  • 12.4. Pharmaceutical and Biotechnology Companies

13. Multiomics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Multiomics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Multiomics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Illumina, Inc.
    • 16.3.3. Danaher Corporation
    • 16.3.4. Roche Holding AG
    • 16.3.5. Agilent Technologies, Inc.
    • 16.3.6. QIAGEN N.V.
    • 16.3.7. Bio-Rad Laboratories, Inc.
    • 16.3.8. PerkinElmer, Inc.
    • 16.3.9. Bruker Corporation
    • 16.3.10. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MULTIOMICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MULTIOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MULTIOMICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MULTIOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MULTIOMICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MULTIOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MULTIOMICS MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MULTIOMICS MARKET SIZE, BY QPCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MULTIOMICS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MULTIOMICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MULTIOMICS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MULTIOMICS MARKET SIZE, BY LIPIDOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MULTIOMICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MULTIOMICS MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MULTIOMICS MARKET SIZE, BY SAMPLE PREPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE AND FOOD TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MULTIOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MULTIOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MULTIOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MULTIOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS MULTIOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS MULTIOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. AFRICA MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL MULTIOMICS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL MULTIOMICS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 341. ASEAN MULTIOMICS MARKET SIZE, BY SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 342. ASEAN MULTIOMICS MARKET SIZE, BY SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 343. ASEAN MULTIOMICS MARKET SIZE, BY OMICS, 2018-2024 (USD MILLION)
  • TABLE 344. ASEAN MULTIOMICS MARKET SIZE, BY OMICS, 2025-2032 (USD MILLION)
  • TABLE 345. ASEAN MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. ASEAN MULTIOMICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. ASEAN MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
  • TABLE 348. ASEAN MULTIOMICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2032 (USD MILLION)
  • TABLE 349. ASEAN MULTIOMICS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 350. ASEAN MULTIOMICS MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 351. ASEAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. ASEAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. ASEAN MULTIOMICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 354. ASEAN MULTIOMICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 355. GCC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 356. GCC MULTIOMICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 357. GCC MULTIOMICS MARKET SIZE, BY TECHNOLOGY, 201